Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)

Recombinant Human Preferentially Expressed Antigen In Melanoma (PRAME) is a purified Prokaryotic Protein. Purity: >90% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Preferentially Expressed Antigen In Melanoma (PRAME). Target Synonyms: MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors. Accession Number: P78395. Gene ID: 23532. Expression Region: Asn416~Leu502. Tag Info: N-terminal His and GST Tag. Theoretical MW: 40kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.